Phosphodiesterase type 5 (PDE5) inhibitors are a class of drugs that relax smooth muscle in blood vessel walls, and they are best known as the medications behind Viagra and Cialis. Four are approved for clinical use: sildenafil, tadalafil, vardenafil, and avanafil. While erectile dysfunction remains the headline application, these drugs have carved out a surprisingly broad set of roles, from treating a dangerous form of high blood pressure in the lungs to easing urinary symptoms caused by an enlarged prostate. Their side effects range from the predictable and mild to a handful of rare but serious concerns that are worth understanding before you take one.
How PDE5 Inhibitors Work
The enzyme PDE5 breaks down a signaling molecule called cGMP. When cGMP accumulates in smooth muscle cells, those cells relax and blood vessels widen. Nitric oxide, released during sexual arousal or by the lining of blood vessels under other circumstances, kicks off cGMP production. PDE5 is the off switch: it chews up cGMP and ends the relaxation. A PDE5 inhibitor blocks that off switch, so cGMP sticks around longer and the vessels stay open wider.
1PubMed. Overview of phosphodiesterase 5 inhibition in erectile dysfunctionThis is why the drugs do not create erections out of thin air. They amplify the body’s existing nitric oxide signal. Without arousal sending that signal in the first place, there is nothing to amplify. The same logic applies outside the penis: wherever PDE5 is expressed and nitric oxide is active, these drugs can relax smooth muscle, which explains the expanding list of therapeutic uses.
Erectile Dysfunction
Treating erectile dysfunction (ED) is the original and most common use. All four approved PDE5 inhibitors have demonstrated strong efficacy. In pooled clinical trials of tadalafil in Asian men, for instance, the 20 mg dose produced successful intercourse in about 70% of attempts, compared with roughly 33% on placebo, and around 85% of men on tadalafil reported improved erections overall.2PubMed Central. Efficacy and safety of tadalafil taken as needed for the treatment of erectile dysfunction in Asian men: results of an integrated analysis Trials have confirmed safety and efficacy across all severities and causes of ED, including cases considered difficult to treat, such as those linked to diabetes or after prostate surgery.3PubMed Central. Tadalafil in the treatment of erectile dysfunction
Head-to-head comparisons suggest tadalafil may have a modest edge over sildenafil in ED score improvements, and daily low-dose tadalafil performs similarly to on-demand dosing.4PubMed Central. Comparative efficacy of on-demand Sildenafil, Tadalafil and daily Tadalafil for treatment of erectile dysfunction: A 12-week randomized controlled study The practical difference often matters more than the statistical one, though, and it comes down to how quickly the drugs kick in and how long they last.
Telling the Four Drugs Apart
All four PDE5 inhibitors work through the same mechanism, but their pharmacokinetic profiles differ enough that the choice between them has real day-to-day implications.
- Sildenafil: Reaches peak blood levels in about an hour, starts working in as little as 30 minutes, and has a half-life of roughly 3 to 5 hours. Effects can last up to 12 hours. A fatty meal slows absorption by about an hour.
- Vardenafil: Similar timing to sildenafil, with a half-life of 4 to 5 hours and efficacy lasting up to 12 hours. Also slowed by food.
- Tadalafil: The outlier. Its half-life is about 17.5 hours and effects can persist for up to 36 hours, which is why it earned the nickname “the weekend pill.” Peak levels take about two hours to reach, but food does not affect absorption.
- Avanafil: The fastest to kick in, with some response reported within about 15 minutes and peak levels reached in 30 to 45 minutes. Its half-life is 3 to 5 hours with a maximum duration of around 6 hours. Like sildenafil and vardenafil, food delays it.
5PubMed Central. The devil is in the details: an analysis of the subtleties between phosphodiesterase inhibitors for erectile dysfunction6Therapeutics and Clinical Risk Management. Avanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility
Tadalafil’s long duration makes it uniquely suitable for daily dosing, which is why it is the only PDE5 inhibitor approved for once-daily use. For men who prefer spontaneity over planning around a pill, that can be a meaningful advantage. Avanafil’s rapid onset, on the other hand, appeals to people who want a shorter lead time before sexual activity. Sildenafil and vardenafil sit in between and remain the most widely prescribed partly because generics are widely available and inexpensive.
Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a condition where blood pressure inside the arteries of the lungs climbs dangerously high, straining the right side of the heart. PDE5 is heavily expressed in lung vasculature, so inhibiting it relaxes pulmonary arteries and lowers that pressure. Sildenafil was originally studied as a heart drug before its detour into ED, and it eventually came full circle: it is now sold under the brand name Revatio specifically for PAH.7PubMed Central. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
The landmark SUPER trial showed that sildenafil improved exercise capacity, functional status, and hemodynamics in patients with symptomatic PAH.8European Cardiology Review. Treatment Selection in Pulmonary Arterial Hypertension: Phosphodiesterase Type 5 Inhibitors versus Soluble Guanylate Cyclase Stimulator Tadalafil is also approved for PAH under the name Adcirca. In both cases, the doses used for PAH are higher than those for ED, and the drugs are taken on a fixed daily schedule rather than as needed.
Lower Urinary Tract Symptoms From an Enlarged Prostate
Tadalafil 5 mg once daily is approved for treating lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland that makes urination difficult or frequent. In dose-finding trials, daily tadalafil at 5 mg improved symptom scores meaningfully compared with placebo, and that dose offered the best balance of benefit and tolerability.9PubMed. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study Both the irritative symptoms (urgency, frequency) and the obstructive ones (weak stream, straining) improved, along with quality-of-life measures.10PubMed. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia
A meta-analysis confirmed that daily tadalafil 5 mg was effective for both LUTS and ED over 12 weeks, which makes it an attractive option for men who have both problems at once.11PubMed. Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta-analysis The exact mechanism in the prostate is still debated; it likely involves relaxation of smooth muscle in the prostate and bladder neck, along with improved blood flow to the lower urinary tract.
Common Side Effects
The most frequent side effects stem from the fact that PDE5 is not limited to the penis or the lungs. It sits in blood vessel walls throughout the body, and when the drug widens those vessels, you get predictable consequences: headache, facial flushing, nasal congestion, and indigestion.12PubMed Central. Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons These tend to be dose-dependent, meaning a higher dose makes them more likely, and they usually fade as the drug clears your system.
Back pain and muscle aches are reported more often with tadalafil than the other three, probably because its longer duration keeps the drug active while you sleep and move through a full day. Dizziness and a slight drop in blood pressure can also occur, particularly when you stand up quickly after taking a dose. For most people, these effects are mild enough to tolerate, and they often lessen with repeated use as your body adjusts.
Vision and Hearing Risks
Sildenafil has a small amount of cross-reactivity with PDE6, an enzyme found exclusively in the photoreceptors of the retina. This is why some users notice a bluish tint to their vision or increased sensitivity to light, especially at higher doses. These visual changes are typically reversible once the drug wears off. More concerning, though rare, are case reports linking sildenafil to a temporary rise in eye pressure and to nonarteritic anterior ischemic optic neuropathy (NAION), a condition where blood flow to the optic nerve is disrupted and vision can be permanently affected.13PubMed Central. Visual Side Effects Linked to Sildenafil Consumption: An Update NAION is extremely uncommon, and proving a direct causal link has been difficult since many of the men affected already had risk factors like diabetes and high blood pressure. Still, anyone who experiences sudden vision loss in one eye after taking a PDE5 inhibitor should seek immediate medical attention and not take the drug again.
Hearing is a less well-known concern. Reports of sudden sensorineural hearing loss have been filed after use of all four PDE5 inhibitors, and an analysis of the FDA’s adverse event reporting system found that sudden hearing loss showed the strongest signal with sildenafil and tadalafil, while vardenafil was more associated with one-sided deafness and avanafil with tinnitus.14Scientific Reports. Phosphodiesterase type 5 inhibitors related hearing impairment: a real world study based on the FDA adverse event reporting system The absolute numbers remain small, and causation has not been definitively established, but the pattern has appeared consistently enough that PDE5 inhibitors are considered a risk factor for sudden deafness.15PubMed Central. Phosphodiesterase Type 5 Inhibitors and sudden sensorineural hearing loss
The Nitrate Interaction
If there is one drug interaction you need to know about, it is this: PDE5 inhibitors must never be combined with nitrate medications. Nitrates, prescribed for angina and found in drugs like nitroglycerin and isosorbide mononitrate, work by flooding the system with nitric oxide. PDE5 inhibitors amplify that same nitric oxide-cGMP pathway. Stack the two together and blood pressure can plummet to life-threatening levels. This combination has caused fatalities.16PubMed Central. Sildenafil (viagra) and the heart
The timing matters too. Because tadalafil stays active for up to 36 hours, the window during which nitrates remain dangerous is much longer than with sildenafil or avanafil. Current guidelines generally recommend waiting at least 24 hours after sildenafil or vardenafil and at least 48 hours after tadalafil before taking any nitrate. Alpha-blockers, sometimes prescribed for BPH, can also lower blood pressure when combined with PDE5 inhibitors, although the interaction is milder. Men on alpha-blockers are typically started on a lower PDE5 inhibitor dose and monitored for dizziness or lightheadedness.
Raynaud’s Phenomenon and Scleroderma
Because PDE5 inhibitors dilate blood vessels throughout the body, they have found a role in conditions where blood flow to the extremities is impaired. Scleroderma, an autoimmune disease that causes hardening and tightening of the skin and connective tissue, frequently involves Raynaud’s phenomenon, where fingers and toes turn white or blue in response to cold or stress as small arteries spasm shut. PDE5 inhibitors have become a first-line treatment among rheumatologists who manage scleroderma-related Raynaud’s and the painful digital ulcers that can develop when blood flow is severely restricted.17PubMed Central. PDE-5 Inhibitors in Scleroderma Raynaud Phenomenon and Digital Ulcers: Current Status of Clinical Trials This use is technically off-label but well-supported by clinical experience and trial data.
High Altitude and Exercise Under Hypoxia
When you ascend to high altitude, lower oxygen levels cause the blood vessels in your lungs to constrict, raising pulmonary artery pressure. In susceptible individuals this can progress to high-altitude pulmonary edema (HAPE), a potentially fatal condition. Because PDE5 inhibitors counteract that pulmonary vasoconstriction, researchers have explored whether sildenafil could prevent altitude-related problems.
A meta-analysis found that sildenafil did lower pulmonary artery systolic pressure at altitude by a few mmHg, with a larger effect above 5,000 meters and during exercise.18PubMed Central. Efficacy of Sildenafil on healthy humans in high‑altitude hypoxia at rest and during exercise: A meta‑analysis However, a placebo-controlled trial in healthy lowlanders at 5,200 meters found that sildenafil did not reduce pulmonary pressure and actually worsened acute mountain sickness scores on the second day.19PubMed. Sildenafil citrate for the prevention of high altitude hypoxic pulmonary hypertension: double blind, randomized, placebo-controlled trial A systematic review concluded that while the mechanism makes sense on paper, there is no conclusive evidence yet that PDE5 inhibitors prevent HAPE in practice.20PubMed Central. Systematic Review of the Effects of Phosphodiesterase-5 Inhibitors and Dexamethasone on High Altitude Pulmonary Edema (HAPE)
For exercise performance at altitude, there is a more interesting signal. Sildenafil improved cardiac output and exercise capacity during hypoxic exercise in a controlled lab study, though it had no measurable effect under normal oxygen conditions.21PubMed. Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia This is relevant for mountaineers and athletes competing at altitude, but it also means PDE5 inhibitors would not be useful as performance enhancers at sea level.
Dementia and Brain Blood Flow
One of the more intriguing research frontiers involves PDE5 inhibitors and the brain. PDE5 is expressed in neurons, blood vessels of the brain, and supporting cells. Animal studies have shown that sildenafil and tadalafil improve performance on memory tasks in mouse models of neurodegeneration, and tadalafil reduced markers of a key Alzheimer’s-related protein after 12 weeks of treatment in mice.22PubMed Central. The effect of phosphodiesterase-5 inhibitors on cerebral blood flow in humans: A systematic review
In humans, the evidence is still early-stage. Real-world patient data suggest that sildenafil and vardenafil users have a lower risk of developing dementia compared with non-users, and neuroimaging studies show that PDE5 inhibitors improve cerebral blood flow.23PubMed Central. PDE5 inhibitor drugs for use in dementia24npj Dementia. Phosphodiesterase‑5 inhibitors and Alzheimer’s disease; a meta‑analysis on clinical studies The association is interesting but far from proof. These are observational findings, and the people taking PDE5 inhibitors for ED may differ from non-users in ways that independently lower dementia risk, such as being more physically active or having better-managed cardiovascular health. A recent clinical trial of acute tadalafil on cerebral blood flow was neutral, suggesting that any cognitive benefit may require chronic use rather than a single dose. Randomized trials specifically designed to test whether PDE5 inhibitors prevent or slow dementia are still needed.
Heart Failure Research
PDE5 is also expressed in heart muscle, and a line of animal research has explored whether sildenafil can protect the heart when it is under chronic pressure overload. In mouse models of heart failure caused by high blood pressure, sildenafil reduced cardiac enlargement, inflammation, fibrosis, and cell death, while improving the heart’s ability to contract and relax.25PubMed Central. Sildenafil stops progressive chamber, cellular, and molecular remodeling and improves calcium handling and function in hearts with pre-existing advanced hypertrophy caused by pressure overload26PubMed. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo Separate work showed that sildenafil preserved the microscopic structures inside heart cells that coordinate calcium signals, helping explain how it maintained pumping function.27PubMed Central. Sildenafil ameliorates left ventricular T-tubule remodeling in a pressure overload-induced murine heart failure model
These results are compelling in animals but translating them to human heart failure has been slower. Some small human studies have shown improvements in exercise tolerance and cardiac efficiency in patients with heart failure who received sildenafil, but large definitive trials have not consistently confirmed a benefit. Heart failure is not an approved indication for any PDE5 inhibitor.
Female Sexual Dysfunction
Given that PDE5 inhibitors increase blood flow to genital tissue, researchers have naturally wondered whether they could help women with sexual dysfunction. The picture is messy. Studies that measured genital blood flow directly found consistent improvements with sildenafil. But studies that asked women to rate their own sexual satisfaction showed mixed results: some positive, some no different from placebo.28PubMed. Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?
A systematic review and meta-analysis found that PDE5 inhibitors generally improved female sexual function compared with placebo, though the body of evidence included some negative trials.29PubMed. Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction A more recent scoping review of studies using sildenafil in women found that four studies demonstrated effectiveness while two did not.30PubMed Central. The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review The disconnect between what happens physiologically and what women report subjectively highlights a genuine complexity: female sexual response is less dependent on genital blood flow alone than male erectile function, and the causes of low desire or arousal difficulty in women are frequently psychological, relational, or hormonal rather than purely vascular. No PDE5 inhibitor is approved for female sexual dysfunction.
Priapism and a Paradoxical Use
Priapism, an erection that will not go away and can damage penile tissue, might sound like the last thing you would want to treat with a drug that promotes erections. But here the biology takes a surprising turn. Recurrent priapism, especially in men with sickle cell disease, appears to involve disordered PDE5 activity rather than simply too much blood flow. The hypothesis is that PDE5 function becomes dysregulated, and chronic low-dose PDE5 inhibitor therapy can restore normal erection cycling and reduce episodes. In a small clinical exploration, long-term PDE5 inhibitor treatment alleviated recurrent priapism in patients with blood disorders as well as idiopathic cases.31PubMed. Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism This counterintuitive application remains a niche use, but it underscores how the relationship between PDE5 and erection is more nuanced than a simple on-off switch.
Hidden PDE5 Inhibitors in Supplements
One of the more alarming public health issues around PDE5 inhibitors has nothing to do with prescription use. Herbal supplements marketed for “male enhancement” or “sexual vitality” are frequently adulterated with undeclared pharmaceutical-grade PDE5 inhibitors. An analysis of 50 herbal dietary supplements found that 74% contained sildenafil, sometimes in quantities far exceeding a normal prescription dose.32PubMed Central. Investigation of the Presence of Sildenafil in Herbal Dietary Supplements by Validated HPLC Method A separate survey of sexual enhancement products sold in the Sacramento, California area found that none declared pharmaceutical ingredients on their labels, and over half contained more than one active PDE5 inhibitor.33Nutrition and Dietary Supplements. Cross-Sectional Survey of Adulterated Sexual Enhancement Products Sold in the Sacramento Area of California
This is dangerous for several reasons. A man who does not know he is taking a PDE5 inhibitor cannot avoid the nitrate interaction described above. The dosages in adulterated products are unpredictable, and the combination of multiple PDE5 inhibitors at unknown levels has never been studied for safety.34Current Opinion in Food Science. Pharmacological and toxicological health risk of food (herbal) supplements adulterated with erectile dysfunction medications If you buy a supplement that promises to enhance sexual performance and it seems to work remarkably well, there is a good chance it contains an actual drug, and that should concern you rather than reassure you.